Candel Therapeutics to present prostate cancer data at ASTRO 2026

August 3, 2026 8:05 AM

Candel Therapeutics, Inc. (Nasdaq: CADL) announced that an abstract was accepted for poster presentation at the 2026 American Society for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found